1. 43 A PREDICTIVE MODEL OF RESPONSE TO ERYTHROPOIETIC STIMULATING AGENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. (April 2015) Authors: Houston, B.L.; Jayakar, J.; Lenis, M.; Mamedov, A.; Wells, R.A.; Buckstein, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis. (April 2017) Authors: Leitch, H.A.; Wells, R.A.; Chodirker, L.; Zhu, N.; Nevill, T.J.; Yee, K.W.L.; Leber, B.; Keating, M.M.; Sabloff, M.; Hilaire, E. St.; Kumar, R.; Delage, R.; Geddes, M.; Storring, J.M.; Shamy, A.; Elemary, M.; Lenis, M.; Francis, J.; Zhang, L.; Buckstein, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion‐dependent patients with myelodysplastic syndromes. Issue 1 (19th October 2016) Authors: Lin, Y.; Saskin, A.; Wells, R. A.; Lenis, M.; Mamedov, A.; Callum, J.; Buckstein, R. Journal: Vox sanguinis Issue: Volume 112:Issue 1(2017) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗